Merger KVSA

Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement

, SPAC Research

Valo Health, LLC, the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process and Khosla Ventures Acquisition Co. (Nasdaq: KVSA), a special purpose acquisition company sponsored by affiliates of Khosla Ventures, LLC, announced today that both companies have mutually agreed to terminate their previously announced agreement and plan of merger, effective immediately.

Both parties decided to terminate the Business Combination based on current market conditions, particularly in the biotechnology area.

Read more